Ad is loading...
DRTS
Price
$2.23
Change
+$0.03 (+1.36%)
Updated
Nov 15 closing price
One day until earnings call
KRYS
Price
$170.74
Change
-$6.65 (-3.75%)
Updated
Nov 15 closing price
105 days until earnings call
Ad is loading...

DRTS vs KRYS

Header iconDRTS vs KRYS Comparison
Open Charts DRTS vs KRYSBanner chart's image
Alpha Tau Medical
Price$2.23
Change+$0.03 (+1.36%)
Volume$16.99K
CapitalizationN/A
Krystal Biotech
Price$170.74
Change-$6.65 (-3.75%)
Volume$351.12K
CapitalizationN/A
DRTS vs KRYS Comparison Chart
Loading...
DRTS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
DRTS vs. KRYS commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRTS is a Sell and KRYS is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (DRTS: $2.23 vs. KRYS: $170.74)
Brand notoriety: DRTS and KRYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRTS: 71% vs. KRYS: 144%
Market capitalization -- DRTS: $156.33M vs. KRYS: $4.91B
DRTS [@Biotechnology] is valued at $156.33M. KRYS’s [@Biotechnology] market capitalization is $4.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRTS’s FA Score shows that 1 FA rating(s) are green whileKRYS’s FA Score has 1 green FA rating(s).

  • DRTS’s FA Score: 1 green, 4 red.
  • KRYS’s FA Score: 1 green, 4 red.
According to our system of comparison, KRYS is a better buy in the long-term than DRTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRTS’s TA Score shows that 2 TA indicator(s) are bullish while KRYS’s TA Score has 2 bullish TA indicator(s).

  • DRTS’s TA Score: 2 bullish, 7 bearish.
  • KRYS’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, DRTS is a better buy in the short-term than KRYS.

Price Growth

DRTS (@Biotechnology) experienced а -1.55% price change this week, while KRYS (@Biotechnology) price change was -14.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

DRTS is expected to report earnings on Mar 06, 2025.

KRYS is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($4.91B) has a higher market cap than DRTS($156M). KRYS YTD gains are higher at: 37.627 vs. DRTS (-25.914). KRYS has higher annual earnings (EBITDA): 120M vs. DRTS (-28.61M). KRYS has more cash in the bank: 560M vs. DRTS (71M). KRYS has less debt than DRTS: KRYS (7.69M) vs DRTS (12.6M). KRYS has higher revenues than DRTS: KRYS (166M) vs DRTS (0).
DRTSKRYSDRTS / KRYS
Capitalization156M4.91B3%
EBITDA-28.61M120M-24%
Gain YTD-25.91437.627-69%
P/E RatioN/A95.92-
Revenue0166M-
Total Cash71M560M13%
Total Debt12.6M7.69M164%
FUNDAMENTALS RATINGS
KRYS: Fundamental Ratings
KRYS
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
7
SMR RATING
1..100
58
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DRTSKRYS
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
70%
Bearish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 12 days ago
60%
Bullish Trend 10 days ago
76%
Declines
ODDS (%)
Bearish Trend 14 days ago
73%
Bearish Trend 3 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
76%
View a ticker or compare two or three
Ad is loading...
DRTS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CETAX12.22N/A
N/A
Centerstone Investors A
HLRZX17.32-0.05
-0.29%
Harding Loevner Intl Small Coms Instl Z
CMRGX9.97-0.08
-0.80%
Calamos Merger Arbitrage I
AFYDX56.76-0.83
-1.44%
American Century Sustainable Equity Y
GTHCX19.48-0.49
-2.45%
Invesco Health Care C

DRTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRTS has been loosely correlated with FRTX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if DRTS jumps, then FRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRTS
1D Price
Change %
DRTS100%
+1.36%
FRTX - DRTS
37%
Loosely correlated
+0.35%
ARDX - DRTS
28%
Poorly correlated
+5.52%
HOOK - DRTS
24%
Poorly correlated
-4.46%
COGT - DRTS
24%
Poorly correlated
-7.77%
KRYS - DRTS
23%
Poorly correlated
-3.75%
More

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with CLDX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
-3.75%
CLDX - KRYS
55%
Loosely correlated
-8.51%
BEAM - KRYS
46%
Loosely correlated
-8.59%
ZLDPF - KRYS
45%
Loosely correlated
-11.35%
BPMC - KRYS
44%
Loosely correlated
-7.28%
RXRX - KRYS
44%
Loosely correlated
-10.64%
More